MetaCap

NRX Pharmaceuticals Insider Trades

NASDAQ: NRXPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.85-0.04 (-1.38%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

NRX Pharmaceuticals insider activity

No NRX Pharmaceuticals insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Javitt Jonathan C (Chairman and Chief Scientist) buying 40,000 shares at $1.17 on Dec 17, 2024. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put NRXP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

NRXP insider transactions

NRX Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Dec 17, 2024Javitt Jonathan CChairman and Chief ScientistBuy40,000$46.80KForm 4
Aug 30, 2023Gorovitz AaronDirectorBuy35,000$11.20KForm 4
Aug 30, 2023Hurvitz ChaimDirectorBuy70,000$20.13KForm 4
Aug 23, 2023Javitt Jonathan CChief ScientistBuy100,000$33.00KForm 4
Aug 22, 2023Javitt Jonathan CChief ScientistBuy200,000$64.40KForm 4
Dec 16, 2022Willard Stephen HCHIEF EXECUTIVE OFFICERBuy50,000$58.50KForm 4
Dec 16, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy30,000$33.00KForm 4
Dec 7, 2022Javitt Jonathan CDirectorSale400,000$400.00KForm 4
Nov 30, 2022Javitt Daniel C.10% OwnerSale8,441$12.70KForm 4
Nov 29, 2022Javitt Daniel C.10% OwnerSale13,730$20.65KForm 4
Nov 28, 2022Flynn Patrick JohnDirectorBuy1,750$2.19KForm 4
Nov 28, 2022Flynn Patrick JohnDirectorBuy2,500$3.10KForm 4
Nov 28, 2022Flynn Patrick JohnDirectorBuy2,500$3.13KForm 4
Nov 28, 2022Flynn Patrick JohnDirectorBuy2,500$3.13KForm 4
Nov 28, 2022Flynn Patrick JohnDirectorBuy2,500$3.13KForm 4
Nov 25, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy7,021$7.79KForm 4
Nov 25, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy600$660Form 4
Nov 25, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy8,716$9.76KForm 4
Nov 25, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy7,021$7.79KForm 4
Nov 25, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy600$660Form 4
Nov 25, 2022VAN VOORHEES SETHCHIEF FINANCIAL OFFICERBuy8,716$9.76KForm 4
Nov 18, 2022Hurvitz ChaimDirectorBuy40,408$44.45KForm 4
Nov 18, 2022Hurvitz ChaimDirectorBuy40,408$44.45KForm 4
Nov 17, 2022Javitt Daniel C.10% OwnerSale33,018$34.74KForm 4
Nov 17, 2022Hurvitz ChaimDirectorBuy171,780$185.52KForm 4
Nov 17, 2022Hurvitz ChaimDirectorBuy171,780$185.52KForm 4
Nov 16, 2022Javitt Daniel C.10% OwnerSale133,719$136.39KForm 4
Nov 16, 2022Hurvitz ChaimDirectorBuy287,812$284.93KForm 4
Nov 16, 2022Hurvitz ChaimDirectorBuy287,812$284.93KForm 4
Nov 11, 2022Javitt Daniel C.10% OwnerSale49,200$49.51KForm 4
Jul 29, 2022Javitt Daniel C.10% OwnerSale784,063$791.43KForm 4
Jul 1, 2022Javitt Daniel C.10% OwnerGift2,000,000—Form 4
Jun 7, 2022Javitt Daniel C.10% OwnerSale86,459$55.86KForm 4
Jun 6, 2022Javitt Daniel C.10% OwnerSale115,657$76.95KForm 4
Jun 3, 2022Javitt Daniel C.10% OwnerSale243,596$171.10KForm 4
Jun 1, 2022Javitt Jonathan CChief ScientistBuy100,000$5.80MForm 4
Jun 1, 2022Javitt Jonathan CChief ScientistBuy100,000$58.00KForm 4
Sep 15, 2021Besthof RobertChief Comm. & Patient OfficerSale40,000$470.40KForm 4
Sep 2, 2021Daigneault AlessandraGeneral Counsel & SecretaryOption exercise13,164$40.41KForm 4
Sep 2, 2021Daigneault AlessandraGeneral Counsel & SecretaryOption exercise18,420$56.55KForm 4
Aug 26, 2021McMaster Herbert RaymondDirectorOption exercise18,300$40.63KForm 4
Aug 23, 2021Daigneault AlessandraGeneral Counsel & SecretarySale33,715$442.00KForm 4
Aug 19, 2021Daigneault AlessandraGeneral Counsel & SecretaryOption exercise27,395$84.10KForm 4
Aug 16, 2021Besthof RobertChief Comm. & Patient OfficerOption exercise63,710$12.74KForm 4
Jul 16, 2021Javitt Daniel C.10% OwnerGift434,594—Form 4
Jul 16, 2021Javitt Daniel C.10% OwnerGift434,594—Form 4
May 24, 2021Gorovitz AaronDirectorAward16,678—Form 4
May 24, 2021Gorovitz AaronDirectorAward8,336—Form 4
May 24, 2021Gorovitz AaronDirectorAward8,336—Form 4
May 24, 2021Gorovitz AaronDirectorAward8,336—Form 4
May 24, 2021Hurvitz ChaimDirectorAward208,443—Form 4
May 24, 2021Hurvitz ChaimDirectorAward1,436,350—Form 4
May 24, 2021Troy DanielDirectorAward43,093—Form 4
May 24, 2021Javitt Daniel C.10% OwnerAward13,971,864—Form 4
May 24, 2021Javitt Jonathan CChief Executive OfficerAward1,422,000—Form 4
May 24, 2021Javitt Jonathan CChief Executive OfficerAward13,348,997—Form 4
May 24, 2021Javitt Jonathan CChief Executive OfficerAward46,332—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related